Long-Term Safety and Efficacy of Prolonged Dual Antiplatelet Therapy according to Baseline Anemia after Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Long-Term Safety and Efficacy of Prolonged Dual Antiplatelet Therapy according to Baseline Anemia after Percutaneous Coronary Intervention

Published:2022 Issue:3 Volume:63 Page:211
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Kim Hun-Tae¹²^ORCID,Lee Jung-Hee¹³^ORCID,Nam Jong-Ho¹^ORCID,Lee Chan-Hee¹^ORCID,Son Jang-Won¹^ORCID,Kim Ung¹^ORCID,Park Jong-Seon¹^ORCID,Shin Dong-Gu¹^ORCID

Affiliation:

1. Cardiovascular Division, Yeungnam University College of Medicine, Yeungnam University Medical Center, Daegu, Korea.

2. Cardiovascular Division, Pohang Semyeong Christianity Hospital, Pohang, Korea.

3. Division of Cardiology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

https://eymj.org/pdf/10.3349/ymj.2022.63.3.211

Reference28 articles.

1. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

2. Long-Term Safety and Efficacy of Extended Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Real-World Practice

3. Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting

4. Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI

5. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of a Polysaccharide Hemostatic Powder and Conventional Therapy for Peptic Ulcer Bleeding;Clinical Gastroenterology and Hepatology;2023-10